Status:

NOT_YET_RECRUITING

Online Access to Clinical Treatment Notes for Outpatients

Lead Sponsor:

Julian Schwarz

Collaborating Sponsors:

Universität zu Köln

Technische Hochschule Brandenburg

Conditions:

Mental Disorders

Chronic Disease

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

This study investigates the feasibility and impact of patient access to clinical notes written by their healthcare providers-a concept known as Open Notes. While international research has already dem...

Eligibility Criteria

Inclusion

  • Patients (General, Module A \& D):
  • Aged 18 years or older
  • Outpatient treatment at one of the four study centers
  • For intervention group: access to an internet-enabled device (e.g. smartphone, tablet, computer) and ability to receive text messages
  • For Module D:
  • Experience with the respective disease or medical field (e.g. via prior treatment experience or basic medical understanding)
  • At least one documented clinical treatment in the internal system of a participating center within the 12 months prior to intervention start
  • Availability of clinically relevant treatment notes (e.g. physician letters, progress notes, discharge summaries, consultation notes) suitable for anonymized analysis
  • Patients (Control Group - Module A):
  • •No requirement for access to an internet-enabled device
  • Healthcare Practitioners (Modules A \& D):
  • Aged 18 years or older
  • Employed at one of the study centers
  • Ability to give informed consent
  • For Module D: experience in relevant clinical field and familiarity with medical terminology and treatment standards
  • Relatives (Module B):
  • Aged 18 years or older
  • Ability to give informed consent
  • Identified as family member, friend, or legal representative of a participating patient
  • Experts (Module E):
  • Demonstrated expertise or professional experience in digital health Relevant experience with telematics infrastructure (TI), HL7 FHIR®, ePA, KIM, TIM, or affiliation with relevant institutions (e.g. gematik GmbH, HL7 Deutschland e.V., mio42 GmbH)
  • Participation in or co-design of health IT interoperability projects
  • Patients and Physicians (Module E):
  • Good proficiency in German (workshops conducted in German)
  • Basic digital literacy and experience with digital technologies in healthcare

Exclusion

  • General:
  • Insufficient German language skills
  • Severe organic brain disorders with cognitive impairment
  • Intellectual disability
  • Acute self-endangerment or danger to others at time of inclusion
  • Lack of capacity to provide informed consent
  • Lack of access to an internet-enabled device and inability to receive text messages (except in control group of Module A)
  • Module D:
  • Clinical notes that cannot be anonymized due to legal, ethical, or technical restrictions
  • Presence of rare diagnoses or unique treatment histories that hinder effective anonymization

Key Trial Info

Start Date :

September 1 2025

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

February 29 2028

Estimated Enrollment :

1092 Patients enrolled

Trial Details

Trial ID

NCT07135726

Start Date

September 1 2025

End Date

February 29 2028

Last Update

August 22 2025

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.